AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

French Minds Cohort: a French Longitudinal and Multimodal Cohort of Patients With Major Mood Disorders, Psychotic Disorders, Autism Spectrum Disorders, and Healthy Controls

RecruitingNAAges 15 Years - 60 YearsAllFondation FondaMental
💬

In plain words

What the trial is, and whether it could suit you

The goal of this study is to learn whether people living with severe psychiatric disorders can be grouped into more homogeneous subgroups, across usual diagnostic categories, based on two key dimensions: social withdrawal and anhedonia (reduced ability to feel pleasure). The study includes adolescents and adults aged 15 to 60 with schizophrenia, a first psychotic episode, bipolar disorder, recurrent or treatment-resistant major depressive disorder, or autism spectrum disorder without intellectual disability, as well as healthy volunteers aged 18 to 60. The main questions it aims to answer are: * Can subgroups of patients sharing a common profile of social withdrawal and anhedonia be identified, with similar clinical, genetic, biological and brain imaging characteristics? * Do other dimensions (cognitive flexibility, neurodevelopmental, sensory and sleep disturbances, impulsivity) and s

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: Patients: * Aged 15 to 60 years at inclusion * Already assessed in a FondaMental expert centre or a First Episode Psychosis (PEP) / RHU PsyCare centre * Signed informed consent (and consent of parents/legal guardians for minors, or of the curator for adults under curatorship) * Confirmed DSM-5 diagnosis at inclusion of at least one of the following: * Non-specific first-episode psychosis\* * Schizophrenia * Bipolar disorder * Major depressive disorder (recurrent or treatment-resistant) * Autism spectrum disorder without intellectual disability * Clinical condition compatible with clinical, biological and imaging assessments * Affiliated with or beneficiary of a social security scheme * Women of childbearing potential: negative blood or urine pregnancy test at inclusion * Agrees to be informed of any abnormality detected on MRI \*Non-specific first-episode psychosis: patients aged 35 or younger, with significant functional impairment (SOFAS), presenting at least two concurrent psychotic symptoms (e.g., hallucinations, delusions, disorganisation) or a first onset of a psychotic disorder (ICD-10 F20-F29) or mood disorder with psychotic features (ICD-10 F30-F39), with the episode lasting more than 7 days and first frank psychotic symptoms having appeared less than 2 years ago. Healthy volunteers (matched to patients by sex and 10-year age group): * Aged 18 to 60 years at inclusion * Signed informed consent * No personal or first-degree family history, in the past 5 years, of: non-specific first-episode psychosis, schizophrenia, bipolar disorder, recurrent or treatment-resistant depressive disorder, or autism spectrum disorder without intellectual disability * No current prescription of antidepressant, antipsychotic, mood stabiliser or psychostimulant for a characterised disorder * No use of antidepressant, antipsychotic, mood stabiliser or psychostimulant in the past 5 years * Condition compatible with clinical, biological and imaging assessments * Affiliated with or beneficiary of a social security scheme * Women of childbearing potential: negative blood or urine pregnancy test at inclusion * Agrees to be informed of any abnormality detected on MRI Exclusion Criteria: Patients: * Unstabilised somatic or psychiatric condition * Contraindication to MRI * Emergency situation, inability to give consent, or under judicial protection (sauvegarde de justice) * Pregnant or breastfeeding women * Refusal to be informed of any abnormality detected on MRI Healthy volunteers: * Psychiatric disorder in the past 5 years (screened with the MINI interview) * Unstabilised somatic condition * Contraindication to MRI * Inability to give consent * Pregnant or breastfeeding women * Refusal to be informed of any abnormality detected on MRI
💊

What it tests

  • 3T Brain MRI
  • Biological Sampling
  • Clinical, Cognitive and Digital Assessments
📍

Where

17 sites
CHU de Besançon
Besançon, France
Centre Hospitalier Charles Perrens
Bordeaux, France
CHU de Brest
Brest, France
Centre Hospitalier Le Vinatier
Bron, France
CHU Clermont Ferrand
Clermont-Ferrand, France
CHU Clermont-Ferrand
Clermont-Ferrand, France
Hopital Louis Mourier
Colombes, France
Hopital Albert Chenevier
Créteil, France

…and 9 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy